Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 8.47% is 184% above its 5-year average of 2.99%, near the high end of its 5-year range (0.62%–8.47%).
As of the fiscal period ended Tuesday, June 30, 2026. 54.94% above its 12-month average of 5.47%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.47%.
DEBT TO ASSETS RATIO
8.47%
DEBT TO ASSETS RATIO AVG TTM
5.47%
DEBT TO ASSETS RATIO AVG 3Y
4.07%
DEBT TO ASSETS RATIO AVG 5Y
2.99%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+54.94%
CURRENT VS 3Y AVG
+108.03%
CURRENT VS 5Y AVG
+183.54%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+9315.53%
vs the sector median at left
Nano-X Imaging Ltd.
Market Cap
$42.83M
Debt to Assets Ratio
8.47%
TTM Avg
5.47%
3Y Avg
4.07%
5Y Avg
2.99%
Market Cap
$42.72M
Debt to Assets Ratio
0.40%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$42.26M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$41.95M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$44.71M
Debt to Assets Ratio
0.57%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$44.72M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nano-X Imaging Ltd. (NNOX) | $42.83M | 8.47% | 5.47% | 4.07% | 2.99% |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $42.72M | 0.40% | N/A | N/A | N/A |
| CVRx, Inc. (CVRX)vs › | $42.99M | 0.64% | N/A | N/A | N/A |
| Filana Therapeutics, Inc. (FLNA)vs › | $42.26M | 0.00% | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $41.95M | 0.03% | N/A | N/A | N/A |
| Precipio, Inc. (PRPO)vs › | $41.83M | 0.16% | N/A | N/A | N/A |
| DarioHealth Corp. (DRIO)vs › | $44.02M | 0.34% | N/A | N/A | N/A |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 0.57% | N/A | N/A | N/A |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | 0.00% | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $45.73M | 0.61% | N/A | N/A | N/A |
Debt/Assets
8.5%
Debt/Equity
0.11
Current Ratio
2.84
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 8.47% |
| 2026-03-31 | 5.24% |
| 2025-12-31 | 4.84% |
| 2025-09-30 | 4.47% |
| 2025-06-30 | 4.32% |
| 2025-03-31 | 3.76% |
| 2024-12-31 | 3.55% |
| 2024-09-30 | 4.24% |
| 2024-06-30 | 3.94% |
| 2024-03-31 | 3.91% |
| 2023-12-31 | 3.84% |
| 2023-09-30 | 2.70% |
| 2023-06-30 | 2.07% |
| 2023-03-31 | 2.05% |
| 2022-12-31 | 1.82% |
| 2022-09-30 | 1.61% |
| 2022-06-30 | 1.63% |
| 2022-03-31 | 1.66% |
| 2021-12-31 | 1.59% |
| 2021-09-30 | 1.91% |
| 2021-06-30 | 0.62% |
| 2021-03-31 | 0.63% |
| 2020-12-31 | 0.61% |
| 2020-09-30 | 0.35% |
| 2020-06-30 | 2.14% |
| 2019-12-31 | 4.43% |
